CCSD Code E5910: Needle Biopsy of Lung Billing Guide

Key Takeaways

CCSD code E5910 needle biopsy of lung covers percutaneous needle biopsy procedures performed under CT or ultrasound guidance in UK private practice.

Pre-authorisation is required by most major UK insurers before performing a needle lung biopsy – check Bupa, AXA Health, and Vitality portals before the procedure.

ICD-10 diagnosis codes must accompany E5910 on private insurance claims; R91.8 and C34 series codes are among the most commonly paired.

Healthcode is the primary e-billing platform for submitting CCSD E5910 claims; missing mandatory fields is a leading cause of rejection.

Accurate clinical documentation – including guidance modality, laterality, and biopsy method – is essential for supporting CCSD E5910 needle biopsy of lung claims.

What is CCSD Code E5910: Needle Biopsy of Lung?

CCSD code E5910 needle biopsy of lung is a procedural billing code used across UK private healthcare to describe a percutaneous biopsy of pulmonary tissue. The code sits within the CCSD Schedule of Procedures, the authoritative reference maintained by the Clinical Coding and Schedule Development Group for private insurer billing in the United Kingdom. When a consultant radiologist or thoracic surgeon performs a needle lung biopsy outside the NHS – whether at an independent hospital, a private outpatient suite, or a day-case facility – E5910 is the code that initiates the billing process.

Understanding how to apply CCSD code E5910 correctly matters because claim errors on interventional radiology procedures attract heightened scrutiny from insurers. A misapplied code – or one submitted without the required supporting diagnosis code – will typically result in a query or outright rejection. This guide covers the procedural definition, documentation requirements, pre-authorisation workflows, ICD-10 pairing, related codes, and Healthcode submission steps for E5910 in UK CCSD billing practice.

CCSD Code E5910 Needle Biopsy of Lung: Procedure Overview

A needle biopsy of the lung is a minimally invasive diagnostic procedure in which a needle is passed through the chest wall to obtain tissue or fluid from a pulmonary lesion, mass, or nodule. In most private practice settings, the procedure is image-guided – either by CT or ultrasound – to ensure precise placement relative to the target site. The British Thoracic Society (BTS) and the Royal College of Radiologists (RCR) both provide clinical guidance on patient selection criteria and procedural technique, which consultants should reference when planning and documenting the intervention.

There are two principal biopsy methods captured under the E5910 CCSD code needle biopsy of lung classification. A fine needle aspiration (FNA) uses a thin-gauge needle to extract cells for cytological analysis. A core needle biopsy uses a larger-bore cutting needle to obtain a tissue core suitable for histopathological assessment. Both approaches may be coded with E5910, but the clinical record should specify which method was used, as this is relevant to documentation and may affect modifier use on certain insurer claim forms.

CCSD Code E5910 Needle Biopsy of Lung: CT-Guided vs Ultrasound-Guided Procedures

CT guidance is the standard approach for most peripheral lung lesions and deeper pulmonary masses, offering precise anatomical localisation and real-time needle tracking. Ultrasound guidance may be appropriate for peripheral lesions abutting the pleura or chest wall, where the lesion is visible sonographically and the patient cannot tolerate the radiation dose or the time required for CT. When submitting the CCSD code E5910 needle biopsy of lung claim, consultants should record the imaging modality used in the operative note, as some insurers request this information during pre-authorisation and post-claim review.

The choice of guidance modality also interacts with any supplementary imaging codes. Where a separate CT or fluoroscopy session is performed solely for biopsy guidance, check whether the insurer’s fee schedule permits billing the guidance code alongside E5910, or whether it is considered bundled. Healix and Cigna have published unbundling guidelines that address this point specifically; review those before submitting dual codes on the same episode of care.

CCSD Code E5910 Needle Biopsy of Lung: Transbronchial Biopsy Distinction

A common source of coding ambiguity is the distinction between a percutaneous needle biopsy (E5910) and a transbronchial biopsy, which is performed endoscopically via a bronchoscope. The approaches differ clinically and carry different CCSD codes. Transbronchial biopsies are coded under the bronchoscopy section of the CCSD schedule. If the procedure was performed bronchoscopically – whether endobronchial ultrasound-guided (EBUS) or via standard bronchoscopy – E5910 does not apply, and using it would constitute a miscoding that insurers may flag during audit. Confirm the operative route before assigning the code.

Documentation Requirements for CCSD Code E5910 Needle Biopsy of Lung

Private insurers processing a CCSD code E5910 needle biopsy of lung claim expect the clinical documentation to substantiate the procedure as performed. At minimum, the operative or procedure note should record the clinical indication for biopsy, the target lesion (location, size, and laterality), the imaging modality used for guidance, the needle gauge and type, the number of passes taken, whether any complications arose, and the specimen destination – that is, whether it was sent for cytology, histology, or both.

Laterality is a specific documentation point that practitioners sometimes overlook. Claims for a right or left lung biopsy should clearly state which side was accessed. Some insurers request radiology reports to be included with the claim submission, particularly on initial referral or where pre-authorisation was conditional on imaging findings. Ensure the radiologist’s or operator’s report is finalised and available at the time of claim, as retrospective requests slow payment and occasionally trigger additional review.

CCSD E5910 Documentation: Consent and Clinical Safety Records

Informed consent documentation is not a billing requirement per se, but the Care Quality Commission (CQC) and UK GDPR both impose obligations on private providers to maintain robust consent records. A signed consent form covering the procedure, its risks (including pneumothorax, bleeding, and the possibility of non-diagnostic sampling), and the patient’s understanding of the process should be present in the clinical record before any claim is submitted. Pabau’s digital forms feature enables practices to capture and store procedural consent electronically, reducing the risk of missing documentation at the point of claim.

Post-procedure monitoring records – typically a chest X-ray to exclude pneumothorax – also form part of the clinical safety trail that insurers may review. Where complications were managed, any additional codes used (such as for chest drain insertion) should be clearly separated and supported by their own documentation. Bundling complications into the E5910 claim without separate documentation is a common source of insurer query.

Pre-Authorisation for CCSD Code E5910 Needle Biopsy of Lung

Pre-authorisation is standard practice for a needle lung biopsy across UK private healthcare. Most major insurers treat this as an invasive diagnostic procedure requiring approval before it is carried out. Submitting a CCSD code E5910 needle biopsy of lung claim without a valid pre-authorisation number will, in most cases, result in rejection or require resubmission with additional justification. Pre-authorisation requirements vary between insurers and may change with policy updates, so practitioners should always verify current requirements directly with the insurer’s provider portal before scheduling the procedure.

CCSD Code E5910 Needle Biopsy of Lung: Bupa Pre-Authorisation Workflow

Bupa requires consultants to obtain prior approval for lung biopsy procedures before the episode of care begins. The authorisation process is managed through Bupa’s provider portal, where the referring consultant submits the clinical indication, relevant imaging findings, and the proposed procedure code. Bupa may request evidence that the lesion meets their clinical criteria for biopsy – particularly for pulmonary nodules where a watching-brief protocol may be considered first. You can verify current CCSD E5910 procedure details through the Bupa code search tool and cross-reference against their fee schedule before submission. For a broader reference on Bupa procedure codes, Pabau’s Bupa CCSD codes guide covers the submission framework in detail.

CCSD Code E5910 Needle Biopsy of Lung: AXA Health and Vitality Pre-Authorisation

AXA Health processes pre-authorisation requests through its specialist forms portal and applies clinical coverage rules that may differ from Bupa’s. Consultants should confirm the relevant fee chapter and submit supporting clinical information – including the referring GP or specialist’s letter – at the time of the authorisation request. The AXA Health specialist procedure codes portal allows providers to look up relevant codes before submission.

Vitality Health uses a fee finder tool that allows providers to look up applicable fee amounts by CCSD code before submitting the authorisation request. The Vitality fee finder is particularly useful for confirming the expected reimbursement range for E5910 under a patient’s specific policy tier, since Vitality operates a tiered fee structure that may affect the approved amount. Always obtain the authorisation reference number before the procedure date and include it on all related claim documents.

CCSD Code E5910 Needle Biopsy of Lung: WPA, Aviva, and Cigna Considerations

WPA, Aviva, and Cigna each maintain their own fee schedules for CCSD-coded procedures and their own pre-authorisation pathways. WPA’s medical fees page provides details on recognition terms and reimbursement levels; Aviva publishes procedure fee guidelines that specify invoicing requirements for CCSD-coded claims; and Cigna operates a UK fee schedule with explicit unbundling rules that apply when multiple codes are submitted for the same episode. For any insurer not listed here, check the provider portal directly. Fee amounts are not reproduced in this article, as rates vary by contract and may change with annual fee schedule reviews.

Manage your CCSD billing workflows in one place

Pabau helps UK private practices organise patient records, clinical documentation, and billing workflows – so your team spends less time chasing paperwork and more time delivering care.

Book a demo

ICD-10 Diagnosis Codes That Pair with CCSD Code E5910 Needle Biopsy of Lung

Most UK private insurers require a valid ICD-10 diagnosis code to accompany the CCSD procedural code on a claim. For CCSD code E5910 needle biopsy of lung, the appropriate diagnosis code depends on the clinical indication at the time the procedure is performed – not the histological result, which may not be available until after the claim is submitted. The guidance below reflects commonly used ICD-10 codes in this clinical context; it is provided as educational reference only and does not constitute definitive coding advice. Consultants should confirm pairing requirements with their insurer and coding advisor.

CCSD Code E5910 Needle Biopsy of Lung: Common ICD-10 Pairings

When the clinical indication is a pulmonary nodule identified incidentally on imaging, R91.8 is frequently used as the primary diagnosis code because the aetiology has not yet been established. Once histology confirms a diagnosis, the claim record may need to be updated if the insurer processes final diagnosis coding rather than presenting-indication coding. Confirm the insurer’s policy on diagnosis code finalisation with your billing team or insurer liaison.

The NHS Classifications Browser provides access to the UK edition of ICD-10 (5th edition), which is the reference standard used in UK private healthcare billing. Consultants who are uncertain about the precise code for a given clinical scenario should cross-reference the tabular list and any coding notes before submitting. Diagnosis code errors are among the most common grounds for insurer claim queries on private healthcare claims management platforms.

Related CCSD Codes and CCSD Code E5910 Needle Biopsy of Lung Positioning

The CCSD Schedule contains several codes that are adjacent to E5910, and choosing the correct one depends entirely on the procedure actually performed. Using a related code when E5910 is the correct descriptor – or vice versa – constitutes a miscoding that insurers may identify at audit. The following codes are the most frequently confused with the CCSD code E5910 needle biopsy of lung.

CCSD E5910 vs Related Lung and Thoracic Biopsy Codes

The CCSD technical guide (October 2025) provides the business rules that govern code selection, bundling, and modifier usage across all sections of the schedule. Practitioners billing for thoracic procedures regularly should keep this document accessible, as it is updated periodically. Changes to bundling rules or code descriptors can affect how E5910 claims are processed without any change to the underlying clinical procedure.

Where a lung biopsy is performed during the same session as a pleural aspiration or drainage, the insurer’s unbundling rules determine whether both procedures may be billed separately. Healix, Cigna, and other insurers with explicit unbundling policies in their fee schedules should be checked before billing multiple thoracic codes on the same date of service. Practices managing multi-procedure claims benefit from a claims management workflow that flags potential bundling conflicts before submission.

Submitting CCSD Code E5910 Needle Biopsy of Lung Claims via Healthcode

Healthcode is the primary electronic billing network for UK private healthcare, connecting consultants and hospitals with insurers for automated claim processing. The majority of major UK private insurers accept and prefer Healthcode e-billing over paper-based submission, and several require it. Submitting CCSD code E5910 needle biopsy of lung claims via Healthcode typically results in faster processing, clearer rejection notifications, and a more auditable billing trail than postal or PDF invoice methods.

CCSD Code E5910 Needle Biopsy of Lung: Healthcode Claim Submission Steps

A Healthcode submission for E5910 requires the following fields to be completed accurately. Incomplete submissions are a leading cause of rejection, and most insurers will not process a claim with missing mandatory data.

1. Provider and patient identification: Confirm the consultant’s Healthcode provider number, the insurer membership number, and the patient’s date of birth match exactly what the insurer holds on file. Name and number discrepancies generate automatic rejections.
2. Pre-authorisation reference: Enter the authorisation number obtained before the procedure. Without this, most insurers will suspend the claim pending manual review.
3. CCSD procedure code: Enter E5910 in the procedure code field. Confirm the code descriptor is “Needle Biopsy of Lung” – do not substitute a similar code based on memory.
4. ICD-10 diagnosis code: Add the relevant ICD-10 code for the clinical indication. This field is mandatory on most insurer claim templates within Healthcode.
5. Date of service and fee: The date should match the procedure date recorded in the clinical notes, not the date of claim preparation. Fees should reflect your contracted or schedule rate with the specific insurer.
6. Supporting documentation: Some insurers require the procedure note or radiology report to be attached at submission. Check the insurer-specific requirements within Healthcode before sending.

Private practices managing multiple consultants and high volumes of CCSD-coded claims benefit from a private GP clinic management platform that integrates clinical documentation with billing workflows. Keeping procedure notes, consent records, and insurer correspondence in a unified system reduces the risk of discrepancies between what was performed and what was submitted. Where Pabau’s CCSD billing support is relevant to your practice type, confirm the specific workflow capabilities directly with the Pabau team.

CCSD Code E5910 Needle Biopsy of Lung: Common Claim Rejection Reasons

Understanding why E5910 claims are rejected is as useful as knowing how to submit them. The most common rejection reasons in UK private practice for interventional radiology procedure codes include: missing or expired pre-authorisation, mismatched patient details, an ICD-10 code that does not clinically support the procedure, incorrect fee relative to the contracted schedule, and a procedure date that falls outside the authorised episode window. Each of these can be avoided through systematic pre-submission checking. A well-designed automated billing workflow can flag missing fields before a claim leaves the practice, reducing rework and improving cash flow.

Expert Resources for CCSD Code E5910 Needle Biopsy of Lung Billing

Expert Picks

Need a full reference for Bupa procedure code submissions? Bupa CCSD Codes covers the complete Bupa billing framework, code lookup process, and insurer submission requirements for UK private practices.

Looking to streamline your private practice billing workflows? Claims Management Software explains how Pabau supports CCSD-coded claim management, documentation linking, and insurer submission tracking.

Want to understand UK GDPR obligations for private healthcare records? GDPR Checklist for UK Clinics outlines the documentation and data handling requirements relevant to clinical records associated with billing submissions.

Managing a private GP or specialist clinic? GP Clinic Software covers the operational features UK private consultants use to manage scheduling, records, and billing in one system.

Conclusion

CCSD code E5910 needle biopsy of lung is a specific procedural code that requires consistent documentation, insurer pre-authorisation, and accurate ICD-10 pairing before a claim can be processed. Each of the major UK private insurers – Bupa, AXA Health, Vitality, WPA, and others – operates its own authorisation workflow and fee schedule, and the rules governing bundling and modifiers differ across those schedules. Practitioners who build systematic documentation checklists and use electronic billing tools to manage their submissions are better positioned to achieve clean first-pass claim rates.

The CCSD schedule is updated periodically, and the October 2025 technical guide revision is the current reference. Reviewing code descriptors and business rules on a regular cycle – rather than only when a claim is rejected – helps practices stay ahead of changes that might otherwise create avoidable billing errors. Reviewed against current CCSD schedule guidance and UK private insurer billing requirements.

Frequently Asked Questions